Podcasts about ozempic

You guys have been asking about peptides… and today we're finally breaking it down.In this episode, I sit down with Dr. Zarrabi from Vitality Med Spa in LA to talk about GLP-1 medications, semaglutide, retatrutide, BPC-157, TB-500, and the growing peptide trend taking over social media.Are peptides safe?Should you use them before plastic surgery?What does “stacking” actually mean?Is this FDA approved… or is it the Wild West?We cover:• GLP-1 medications for weight loss (Ozempic-style drugs)• Microdosing and biohacking• Compounding pharmacies vs brand-name pens• Certificate of analysis & quality control• Peptides for healing and recovery• The potential risks nobody talks about• Why you need to check credentials before injecting anythingIf you're a woman in your 30s prepping for surgery and thinking about losing 15–20 pounds first… this episode is for you.As always, we're not here to sell you hype. We're here to give you clarity.FOLLOW THE CONVERSATION

Dr Natasha Barnes returns to share her expertise on climbing and strength training and how these principles apply broadly to everyone, including thoughts about:-Are lighter climbers better climbers-The problem with focusing on weighing less as a performance enhancer in climbing-Is disordered eating more prevalent in climbing and weight class sports?-Are more climbers coming around to the value of strength training-The story behind Natasha saying “The lightest I've ever been was also the most broken I've ever been”-Why climbing may be a great outlet for adults to put more fun and play into their lives-When you would benefit from putting on weight and muscle for your sport-How to enhance strength without gaining weight-Why squatting is better than doing pistol squats for most training goals-The problem with feats of strength on social media, that aren't useful training methodologies-How can someone reduce the chance of injury when starting a new program-Is climbing a safe activity-How people end up increasing their risk of injury in training and climbing-And much moreIG: @natashabarnesCHAPTERS00:46 Are lighter climbers better02:10 Free solo and El Capitan03:24 Calculated risk and preparation05:34 Strength to weight myth07:07 Technique over weight loss07:47 Eating disorders in climbing09:22 Leg strength and injuries10:48 Olympic climbing explained11:36 Sponsor break — RP app12:59 Why strength training matters14:00 Longevity and pro trends15:44 “Lightest and most broken”17:43 Disordered eating behaviors19:56 Strength without weight gain21:42 Programming for strength23:41 Body fat sweet spot24:43 Society and being smaller26:14 Ozempic and media extremes28:27 Role models and responsibility28:48 Celebrity body scrutiny30:19 Pistol squats vs real strength33:54 Climbing parlor tricks35:27 New program new injury38:12 Autoregulation with RPE40:13 Underprepared tissue injuries42:52 Why climbing feels like play44:02 How to start climbing46:54 Climbing injury rates48:05 Aging vs undertraining53:33 Bone density comebacks54:40 Where to find NatashaSUPPORT THE SHOWIf this episode helped you rethink body weight, strength, or performance, you can support the show by:• Subscribing and checking out more episodes• Sharing it on your social media (tag me — I'll respond)• Sending it to someone interested in climbing or athletic performanceFOLLOW ANDREW COATESInstagram: @andrewcoatesfitnesshttps://www.andrewcoatesfitness.comPARTNERS AND RESOURCESRP Strength App (use code COATESRP)https://www.rpstrength.com/coatesJust Bite Me Meals (use code ANDREWCOATESFITNESS for 10% off)https://justbitememeals.comMacrosFirst – FREE Premium TrialDownload MacrosFirst and during setup you'll be asked “How did you hear about us?”Type in: ANDREWKNKG Bags (15% off)https://www.knkg.com/Andrew59676Versa Gripps (discount link)https://www.versagripps.com/andrewcoatesTRAINHEROIC – FREE 90-Day Trial (2 steps)Go to https://www.trainheroic.com/liftfreeReply to the email you receive (or email trials@trainheroic.com) and let them know Andrew sent you

Today's episode of The Rizzuto Show might be the most “2026 energy” thing we've ever done — and that's saying something for a daily comedy show that thrives on chaos.First up: Liquid Death has created a $495 Bluetooth speaker urn called the “Eternal Playlist,” so when you're cremated, your ashes can keep vibing to Spotify. Yes, this is real. Yes, there's a stat about reducing your odds of haunting. And yes, Moon almost added it to his cart. We break down the marketing genius (or insanity), debate whether ghosts prefer classic rock or lo-fi beats, and ask the real question: who is this actually for?Then we dive headfirst into the wildest piece of funny celebrity gossip of the week. Bonnie Blue — an OnlyFans creator — claims she's pregnant after what she called a “breeding mission” involving 400 guys. Naturally, the internet immediately tagged Maury Povich. We discuss whether Maury should come out of retirement, whether we should host the paternity special ourselves in St. Louis, and how many DNA swabs King Scott is willing to sort through before lunch. It's entertainment gossip meets absurd reality TV, and somehow it only gets weirder.As if that wasn't enough, the Rock and Roll Hall of Fame nominations dropped, and the studio turned into a full-blown debate club. Wu-Tang Clan. Sade. Oasis. Mariah Carey. Does the Rock Hall still matter? Does any award show? Do artists secretly care even when they pretend they don't? It's sarcastic humor, passionate music arguments, and classic Rizz Show energy all rolled into one.This episode is peak funny podcast chaos — part comedy podcast, part music nerd fight, part daily humor therapy session for St. Louis and beyond. If you love pop culture commentary, comedy news, weird headlines, and the kind of daily show that spirals off topic in the best possible way, this one's for you.And yes… we still want to know who's buying that urn.Follow The Rizzuto Show → https://linktr.ee/rizzshow for more from your favorite daily comedy show.Connect with The Rizzuto Show Comedy Podcast online → https://1057thepoint.com/RizzShow.Hear The Rizz Show daily on the radio at 105.7 The Point | Hubbard Radio in St. Louis, MO.Heart Attack Grill 'spokesman' dies after apparent heart attackThe car with $8,660 in tickets that nobody will towWhat is sepsis, developed by UK woman who lost 4 limbs, after dog lick?What Does It Mean When a Dog Paws You? Decoding Your Canine's CommunicationDeath isn't the end: Meta patented an AI that lets you keep posting from beyond the graveNovo Nordisk to cut US list prices of Ozempic, Wegovy as of 2027‘Plastic Eating' Trend for Weight Loss Is Going Viral in ChinaSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode, Mike is joined by Reed Davis, founder of FDN (Functional Diagnostic Nutrition) for a conversation around functional health. What does it mean to take a "functional" approach to health? How do you get to the root cause of your symptoms and understand what your body is trying to tell you? Reed helps to answer these questions and a whole lot more in a very informative conversation!Exclusive opportunity for Mind Over Macros listeners from FDN!  Tune in to the “FDN Methodology in Action” case study series where you'll see exactly how FDN practitioners interpret lab results and create custom protocols that get results, no matter what symptoms clients present with at: http://www.fdntraining.com/millner26------------------------------------------------Click here to apply for coaching!For some amazing resources and to be a part of a badass community, join our FB group HEREThe personality assessment is now available online! Click here to take the assessment and find out what your personality tells us about the way you should be training and eating.Take the assessment here!To learn more about Neurotyping, visit www.neurotypetraining.comFollow Mike on IG at @coach_mike_millner

Send Zorba a message!Dr. Zorba explains the importance of calcium scores to a caller, and how it relates to cholesterol. He reviews new research that shows PPIs (stomach acid-reducing drugs) may not increase stomach cancer risk. Zorba also discusses GLP-1 drugs vs. natural methods for losing weight, and shares his recipe for sinus rinse. The Grammar Cops chime in, and we hear a Mom Joke from one of our listeners.Support the showProduction, edit, and music by Karl Christenson Send your question to Dr. Zorba (he loves to help!): Phone: 608-492-9292 (call anytime) Email: askdoctorzorba@gmail.com Web: www.doctorzorba.org Stay well!

Send a textIn this episode of the Causes or Cures Podcast, Dr Eeks speaks with Dr. Sam West, a researcher at the University of Oxford, about his study on what happens after people stop taking GLP 1 weight loss medications.While much of the attention has focused on how these drugs work while people are taking them, this conversation looks at what happens when people stop. Dr West discusses how quickly weight tends to return (and how much), what happens to cardiometabolic markers after stopping treatment, and how these outcomes compare with weight regain after behavior-based interventions.They also explore what these findings mean in practice, including long-term weight maintenance, patient expectations, and how insurers may weigh coverage for these medications. This episode offers important real world context for one of the most widely discussed drug classes in medicine today.Dr. Sam West is a postdoctoral researcher with the Health Behaviours team based in the Department of Primary Care Health Sciences at the University of Oxford. He completed his PhD with the Nutritional Physiology Research Group at the University of Exeter, where his research centred around assessing how modulating dietary protein form influences postprandial skeletal muscle metabolism. His current research focuses on understanding how lifestyle (diet and exercise) and pharmaceutical interventions can be used in the treatment and management of obesity and type 2 diabetes.Work with me? Perhaps we are a good match.You can contact Dr. Eeks at bloomingwellness.com.Follow Eeks on Instagram here.Follow Public Health is WeirdOr Facebook here.Or X.On Youtube.Or TikTok.SUBSCRIBE to her WEEKLY newsletter here!Support the show

Send Zorba a message!Dr. Zorba explains the importance of calcium scores to a caller, and how it relates to cholesterol. He reviews new research that shows PPIs (stomach acid-reducing drugs) may not increase stomach cancer risk. Zorba also discusses GLP-1 drugs vs. natural methods for losing weight, and shares his recipe for sinus rinse. The Grammar Cops chime in, and we hear a Mom Joke from one of our listeners.Support the showProduction, edit, and music by Karl Christenson Send your question to Dr. Zorba (he loves to help!): Phone: 608-492-9292 (call anytime) Email: askdoctorzorba@gmail.com Web: www.doctorzorba.org Stay well!

In this episode of The Bubba Dub Show, Bubba Dub delivers one of his REAL, RAW, and UNFILTERED rants yet!

Send a textMost people think body image is about weight.It's not.Body image is about the story you learned about yourself — often long before you understood what calories or cellulite even were.In this episode, we explore:What body image actually is (and why it's not just about the mirror)How childhood experiences shape the way you see yourselfWhy we often perceive our bodies inaccuratelyThe emotional triggers that intensify body dissatisfactionWhy self-criticism doesn't create sustainable weight lossWhy even people who lose weight — including those using GLP-1 medications — can still feel deeply unhappy in their bodiesIf you've ever believed:“I'll feel better about myself when I'm thinner,” this episode gently challenges that idea.This is not about forced body positivity.It's about understanding the psychology behind body image — and learning how to stop letting it quietly run your life.Because your life is happening now.Not ten kilos from now.Thanks for listening, I hope this episode will be helpful.Philippe

Novo Nordisk announced on Tuesday that it plans to cut the list prices of its blockbuster weight-loss and diabetes drugs Ozempic and Wegovy by up to fifty percent starting January first, twenty twenty-seven. The Danish company stated that various doses of these medications, which contain the active ingredient semaglutide, will drop to six hundred seventy-five dollars per month. This represents a fifty percent reduction for Wegovy and a thirty-five percent cut for Ozempic, with the same price applying to Rybelsus pills. Fox Business reports that Novo Nordisk executive Jamey Millar explained the move aims to help more than one hundred million Americans with obesity and thirty-five million with type two diabetes by lowering out-of-pocket costs, especially for those on high-deductible health plans. CBS News notes this comes amid fierce competition from rivals like Eli Lillys Mounjaro and Zepbound, as well as cheaper compounded versions from telehealth providers. The price slash will align with lower Medicare rates for older Americans but will not affect direct-to-consumer prices, where Wegovy already sells for three hundred forty-nine dollars.In related news, Oprah Winfrey has shared fresh insights on her use of GLP-one medications like those in the Ozempic family. In a recent NBC Connecticut discussion tied to her book Enough, co-authored with Yale Obesity Research Center director Doctor Ania M. Jastreboff, Winfrey reflected on stopping the shots cold turkey on her seventieth birthday in January twenty twenty-four after gaining clarity that obesity drives overeating due to the bodys enough point, a genetically influenced weight set point. She tried maintaining her loss through diet and exercise alone but regained twenty pounds over twelve months, realizing these drugs are a lifelong tool, much like blood pressure medication. Doctor Jastreboff emphasized in the interview that the medications recalibrate this enough point in the brain, reducing hunger signals and fat storage, countering the bodys drive to regain weight. Winfrey, who pays out of pocket for friends unable to afford the shots, urges ending shame around obesity, calling it a disease not a personal failing. She stresses combining drugs with healthy habits for sustainable health, not just looks.These developments highlight growing accessibility and realism around GLP-one drugs amid evolving expert views.Thanks for tuning in, listeners, please subscribe, come back next week for more, and remember this episode was brought to you by Quiet Please podcast networks. For more content like this, please go to Quiet Please dot Ai.Some great Deals https://amzn.to/49SJ3QsFor more check out http://www.quietplease.aiThis content was created in partnership and with the help of Artificial Intelligence AI

Een jaar lang scheten aandeelhouders van Wolters Kluwer in hun broek voor wat er daar aan zat te komen. Het verdienmodel van het databedrijf zou onderuit gehaald worden door AI-bedrijven die het allemaal beter en sneller gaan kunnen. Waardoor de beurskoers in een jaar tijd met ruim 60 procent daalde. Alleen... dat blijkt nu behoorlijk paniekvoetbal. De kwartaalcijfers laten namelijk een ander beeld zien. Omzet en winst stijgen. En Wolters Kluwer bewijst het ongelijk van beleggers nog even extra: want vooral de cloud-activiteiten groeien hard, met 15 procent. Een afscheid in stijl voor ceo Nancy McKinstry, wiens laatste kwartaal dit was. Deze aflevering kijken we of aandeelhouders die zijn vertrokken, nu reden hebben om terug te keren.Hebben we het ook over een ander beursdrama, maar dan in Denemarken. Dat van Novo Nordisk. De maker van onder meer Ozempic had een voorsprong met hun afvalmedicatie, maar werd keihard ingehaald door de concurrentie. En zag het aandeel zelf op een crashdieet gaan. Van het meest waardevolle Europese beursbedrijf, naar een van de beurslosers. Maar die tijd is misschien wel voorbij, want Novo Nordisk heeft iets verzonnen. Het gaat de prijzen halveren.Hoor je ook meer over de State of the Union. Trumps speech heeft een record gebroken. Nog nooit duurde dat politieke praatje zo lang. Maar of het ook een beetje inhoudelijk was, dat bespreken we deze aflevering. Zo wil Trump de inkomstenbelasting inruilen voor.... tarieven! Te gast: Martine Hafkamp van Fintessa Vermogensbeheer BNR Beurs is een journalistiek onafhankelijke productie, mede mogelijk gemaakt door Saxo. Over de makers: Jelle Maasbach is presentator van BNR Beurs en freelance financieel journalist. Zijn favoriete aandeel om over te praten is Disney, maar daar lijkt hij de enige in te zijn. Sinds de eerste uitzending van BNR Beurs is 'ie er bij. Maxim van Mil is presentator van BNR Beurs en journalist bij BNR, waar hij zich focust op de financiële markten en ontwikkelingen in de tech-wereld. Je krijgt hem het meest enthousiast als hij kan praten over ASML, of oer-Hollandse bedrijven zoals Ahold of ABN Amro. Jorik Simonides is presentator van BNR Beurs, economieredacteur en verslaggever bij BNR. Hij wordt er vooral blij van als het een keer níet over AI gaat. Milou Brand is presentator van BNR Beurs, freelance podcastmaker en columnist bij het Financieele Dagblad. Jochem Visser is presentator van BNR Beurs, maakt Beursnerd XL en de podcast Onder Curatoren. Vraag hem naar obscure zaken op financiële markten en hij vertelt je waarom het eigenlijk nóg leuker is dan je al dacht. Over de podcast: Met BNR Beurs ga je altijd voorbereid de nieuwe beursdag in. We praten je in een kleine 25 minuten bij over alle laatste ontwikkelingen op de handelsvloer. We blijven niet alleen bij de AEX of Wall Street, maar vertellen je ook waar nog meer kansen liggen. En we houden het niet bij de cijfers, maar zoeken ook iedere dag voor je naar duiding van scherpe gasten en experts. Of je nu een ervaren belegger bent of net begint met je eerste stappen op de beurs, de podcast biedt waardevolle inzichten voor je beleggingsstrategie. Door de focus op zowel de korte termijn als de lange termijn, helpt BNR Beurs luisteraars om de ruis van de markt te scheiden van de essentie. Van Musk tot Microsoft en van Ahold tot ASML. Wij vertellen je wat beleggers bezighoudt, wie de markten in beweging zet en wat dat betekent voor jouw beleggingsportefeuille.See omnystudio.com/listener for privacy information.

The boys talk vacation plans, parenting potential artistic phenoms, waiting in the truck, and Ozempic side effects Boeing didn't see coming. Follow Sebastian: @SebastianComedy Follow Pete: @PeteCorreale To watch the podcast on YouTube: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://bit.ly/PeteAndSebastianYouTube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Don't forget to follow the podcast for free wherever you're listening or by using this link: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://bit.ly/PeteAndSebastian⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ If you like the show, telling a friend about it would be amazing! You can text, email, Tweet, or send this link to a friend: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://bit.ly/PeteAndSebastian⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ For Sebastian's tour dates, go to: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.sebastianlive.com/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ For Pete's tour dates, go to: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.petecorreale.com/⁠⁠⁠⁠⁠⁠ Sign up for your one-dollar-per-month trial today at https://shopify.com/thecast It's time to upgrade your denim with Rag & Bone. For a limited time, our listeners get 20% off their entire order with code THECAST at https://rag-bone.com Learn more about your ad choices. Visit podcastchoices.com/adchoices

The Pentagon says an attack on Iran may lead to significant risks for U.S. soldiers, allies and resources. The Wall Street Journal’s Alex Ward joins to discuss what one of the military’s top leaders is saying about the situation. Netflix’s bid to buy Warner Brothers just got a little more complicated. Deadline’s Dominic Patten explains why the DOJ is now involved. GLP-1 drugs such as Ozempic have exploded in popularity for their weight-loss effects. Dhruv Khullar of the New Yorker considers how they could be used to treat conditions like addiction. Plus, record snowfall hit parts of the northeast as a massive winter storm moved through, Mexico is experiencing more violence after the country’s top drug lord was killed, and President Trump prepares for his State of the Union address. Today’s episode was hosted by Yasmeen Khan.

Ozempic and other GLP-1 drugs have had a major impact in their short time on the market—currently, one in eight Americans say that they have been on GLP-1 drugs. As tens of millions of people take these medications, anecdotal evidence has emerged that they have a positive effect on alcohol abuse and drug addiction. Researchers are starting to run trials of the drugs for these purposes, and some speculate that GLP-1 drugs could even affect addiction behaviors such as gambling and online shopping. The physician and New Yorker medical correspondent Dhruv Khullar spoke with scientists and patients. “Over the course of my reporting,” he tells David Remnick, “I became more and more bullish on the idea that these are actually going to be really important molecules for the treatment of addiction.” Dhruv Khullar's “Can Ozempic Cure Addiction?” was published on February 9th. New episodes of The New Yorker Radio Hour drop every Tuesday and Friday. Join host David Remnick as he discusses the latest in politics, news, and current events in conversation with political leaders, newsmakers, innovators, New Yorker staff writers, authors, actors, and musicians.

Whole body health and weight management go hand-in-hand. Across the nation, weight gain has become a chronic issue. The current big pharma push it for products that use GLP-1 receptor agonists that mimic the GLP-1 hormone in the body. Ozempic is an example of this. These products require sustained use while suppressing the bodies natural production of GLP-1. The objective is to get the body to rebalance and produce that natural GLP-1 hormone. That is what the GLP-1 Support System from Yongevity does. It is a healthy way to stimulate the body and build a weight management approach to health that empowers the body to express itself as it should. In today's show, we dig into the GLP-1 Support System and how this product in conjunction with the Foundation Pack 2.5 offers a healthy and natural approach to weight management. #BardsFM_HealthAndWellness #WeightManagement #Nutrification Bards Nation Health Store: www.bardsnationhealth.com EnviroKlenz Air Purification, promo code BARDS to save 10%: www.enviroklenz.com EMPShield protect your vehicles and home. Promo code BARDS: Click here MYPillow promo code: BARDS >> Go to https://www.mypillow.com/bards and use the promo code BARDS or... Call 1-800-975-2939.  White Oak Pastures Grassfed Meats, Get $20 off any order $150 or more. Promo Code BARDS: www.whiteoakpastures.com/BARDS BardsFM CAP, Celebrating 50 Million Downloads: https://ambitiousfaith.net Morning Intro Music Provided by Brian Kahanek: www.briankahanek.com Windblown Media 20% Discount with promo code BARDS: windblownmedia.com Founders Bible 20% discount code: BARDS >>> TheFoundersBible.com Mission Darkness Faraday Bags and RF Shielding. Promo code BARDS: Click here EMF Solutions to keep your home safe: https://www.emfsol.com/?aff=bards Treadlite Broadforks...best garden tool EVER. Promo code BARDS: TreadliteBroadforks.com No Knot Today Natural Skin Products: NoKnotToday.com Health, Nutrition and Detox Consulting: HealthIsLocal.com Destination Real Food Book on Amazon: click here Images In Bloom Soaps and Things: ImagesInBloom.com Angeline Design: AngelineDesign.com DONATE: Click here Mailing Address: Xpedition Cafe, LLC Attn. Scott Kesterson 591 E Central Ave, #740 Sutherlin, OR  97479

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: big updates for stem cell and islet transplants, new pen option for Zepbound, an implantable insulin pump moves forward and more! Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  T1D Screening info All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Episode transcription with links: Welcome! I'm your host Stacey Simms and this is an In The News episode.. where we bringing you the top diabetes stories and headlines happening now. A reminder that you can find the sources and links and a transcript and more info for every story mentioned here in the show notes. Quick reminder: I'm just back from MNO DC and I'm exhausted. But it's the best kind of tired. We had an incredible time – hope you can join us in Nashville. With a reminder that we have our first Club 1921 in Nashville – that's our educational dinner series for HCPs and patient leaders. All the info is over at diabetes-connections.com events/     Okay.. our top story this week: XX An "immune system reset" eliminated Type 1, diabetes in mice in a study conducted at Stanford Medicine without immune suppressant medications. This was a combined transplant of blood stem cells and insulin-producing pancreatic islet cells from a donor whose immune profile did not match the recipient. The dual transplant approach both restored insulin production and retrained the immune system. For the full six months of the experiment, the animals did not need insulin injections or immune suppressive medications. Challenges remain using this approach to treat Type 1 diabetes. Pancreatic islets can be obtained only after death of the donor, and the blood stem cells must come from the same person as the islets. It is also unclear whether the number of islet cells typically isolated from one donor would be enough to reverse established Type 1 diabetes. But the researchers are working on solutions, which could include generating large numbers of islet cells in the laboratory from pluripotent human stem cells, or finding ways to increase the function and survival of transplanted donor islet cells. https://scitechdaily.com/stanford-scientists-cure-type-1-diabetes-in-mice-without-insulin-or-immune-suppression/ XX An electronic implant interlaced with islet cells is being looked at to treat type 1. Researchers at the University of Pennsylvania School of Medicine worked with engineers at Harvard University to combine stem-cell biology with soft electronics. They inserted an ultrathin, flexible mesh of conductive wires — thinner than a human hair — into developing pancreatic tissue. As the cells assembled into clusters, the mesh became woven through them. The electronics can record the faint electrical signals produced by the cells that control insulin release. They can also deliver small pulses of electricity back to the cells.   After several days, the cells began to behave more like mature islets. Their internal signalling shifted, neighbouring cells started working in concert and insulin release became stronger and better timed.  Very early on here – and the transplanted cells still need to be protected from being attacked by the immune system. https://www.thetimes.com/uk/science/article/first-cyborg-pancreas-implants-type-1-diabetes-nxkv8r0fp?gaa_at=eafs&gaa_n=AWEtsqeJYYUF9TMR-GgGUG92hPyog-ISeiqGIgdyaaIKKcpvhtoftGiUaaOtQeG0NWI%3D&gaa_ts=699c50d4&gaa_sig=w-PQ0ArosZSznYDSWEzt8aQg4WC0FF5ZFRt9NedO5sSTL2FyWzupH8eSG7RCy2S8TQnlHOeKCudANWm1MNI59w%3D%3D XX Katie Beth (hand) Eledon trial – aaron kowalski post linkedin. Last fall we told you about promising results from Eledon's drug to prevent islet transplantation rejection in type 1 diabetes. The first six patients no longer had to inject or infuse insulin.. the trials continue and this month one of the patients – Katie Beth Hand – began posting about her experiences one month in, on social media, she says she's off basal insulin already and in range 99 percent of the time. She is also encouraging people to learn more about support the islet act https://lnkd.in/e8pQ7_Y7 XX This is a bill introduced last November which would change the wording on pancreatic cell transplants. The problem is that islets are classified as drugs rather than organs, making transplantations difficult for medical teams and centers to preform due to accessibility. Insurance companies are also less likely to provide reimbursements for treatment, which can cost hundreds of thousands of dollars. The official Journal of The Transplantation Society estimates the cost at about $140,000. The bill went to the senate committee of Health, Education, Labor, and Pensions in early November. No other action has been taken since then. https://www.wtoc.com/2026/02/19/bluffton-family-advocates-islet-act-help-diabetic-son/ XX Big change for the obesity drug Zepbound – now available in the multi dose KwikPen. This is a month's worth of doses in a single pen.. and it's multi dose – you can adjust it. Cash-paying patients can get the multi-dose device, called KwikPen, on the company's direct-to-consumer website, LillyDirect. Prices start at $299 per month for the lowest dose level. Until now, you could only get zepbound in a single dose auto injector or a sing dose vial. In a release, Lilly said the Food and Drug Administration approved a label expansion for Zepbound to include the multi-dose device. The KwikPen is already used for other drugs, such as Lilly's popular diabetes medication, Mounjaro – which is the same medication as zepbound, they're both tirzepitide. https://www.cnbc.com/2026/02/23/eli-lilly-launches-zepbound-obesity-drug-pen-one-month-doses.html   XX For years, researchers have observed that people who live at high elevations,  tend to develop diabetes less often than those at sea level. Although the trend was well documented, the biological explanation behind it was unclear. Scientists now say they have identified the reason. Their research shows that in low oxygen environments, red blood cells begin absorbing large amounts of glucose from the bloodstream. Their work showed that when oxygen is limited, red blood cells use glucose to generate a molecule that helps release oxygen to tissues. This process becomes especially important when oxygen is in short supply. The researchers also found that the metabolic benefits of prolonged hypoxia lasted for weeks to months after mice were returned to normal oxygen levels. They then evaluated HypoxyStat, a drug recently developed in Jain's lab that mimics low oxygen exposure. HypoxyStat is taken as a pill and works by causing hemoglobin in red blood cells to bind oxygen more tightly, limiting the amount delivered to tissues. In mouse models of diabetes, the medication completely reversed high blood sugar and outperformed existing treatments. https://www.sciencedaily.com/releases/2026/02/260221060952.htm XX Watching this one closely – Portal Diabetes gets FDA breakthrough device designation for its implantable insulin pump system. This is a system that includes not just a device that's implanted into the abdomen, but also a new, temperature stable insulin. It will work with – quote – "modern" CGM technology with a fully closed loop - and aims to deliver a functional cure for type 1. While reports say Portal's system is the first in the US – there was an implantable pump developed and used by about 500 people worldwide, including about 100 in the US – by MiniMed. Medtronic bought the company and in 2007 they stopped that program. Portal Diabetes expects to begin clinical trials on its combination system around the fourth quarter of 2027. https://www.drugdeliverybusiness.com/portal-diabetes-fda-breakthrough-implantable-insulin-pump/ XX Sequel Med Tech and Senseonics (NYSE:SENS) today announced the full U.S. launch of their CGM and insulin pump integration. That's the eversense cgm and twist pump. Sequel said its full launch with Eversense 365 makes twiist available with two compatible CGMs. twiist also pairs with the Abbott FreeStyle Libre 3 Plus sensor. Eversense 365, an implantable system, rests under the skin for the duration of a year. Users can change its external, silicone-based adhesive daily with almost no skin reactions. https://www.drugdeliverybusiness.com/sequel-senseonics-full-launch-twiist-eversense/ XX Right back with a Dexcom update, and a look at which type of diet reduces insulin use overall.. right after this: -- Back to the news.. Dexcom is watching for expanded Medicare coverage of its continuous glucose monitors to people with Type 2 diabetes who don't take insulin. CEO Jake Leach told investors on Thursday that the company has been "sitting here waiting for a coverage decision" from the Centers for Medicare and Medicaid Services Dexcom started to see commercial coverage unlock for Type 2, non-insulin users toward the end of last year, Leach said. He expects broader Medicare coverage for that group would allow nearly 12 million people to access CGMs.     In the meantime, the American Diabetes Association updated its guidelines last year to recommend clinicians consider using CGMs for Type 2 diabetes when patients are taking glucose-lowering medications other than insulin. Leach said that real world data the company has been generating supports that decision, and that Dexcom has launched a registry for non-insulin users. https://www.medtechdive.com/news/dexcom-seeks-expanded-medicare-coverage-of-cgms-for-type-2-diabetes/812223/ XX Medtronic's separation of MiniMed is not yet complete.. but continues to move forward. The company has submitted their next pump – MiniMed Flex – to the FDA. This is a pump smaller than the 780G but uses the same reservoirs and infusion sets. It will also work with both the Simplera Sync and Instinct sensors. Medtronic also began a U.S. pivotal study for Vivera, its third-generation algorithm for automated insulin delivery. It also remains set to submit its MiniMed Fit patch pump system to the FDA by the coming fall. https://www.drugdeliverybusiness.com/medtronic-submits-minimed-flex-fda-q3/ XX A study modelling how genes may influence a child's body mass index over time has found that BMI at age 10 and overall growth rate between ages one and 18 might be important factors, as the two are more likely linked to diabetes, high cholesterol, and heart disease in later life. Nearly 66,000 BMI measurements from around 6,300 children and adolescents aged one to 18 were analysed to understand the role of genes.     "Future research is needed to help identify the most effective ages to prevent obesity or poor growth for long-term benefit." https://www.ndtv.com/health/bmi-at-age-10-growth-rate-up-to-age-18-are-important-factors-for-diabetes-heart-disease-study-11125146 XX A low-fat vegan diet—without cutting calories or carbs—may help people with type 1 diabetes significantly reduce how much insulin they need. In a new analysis published in BMC Nutrition, participants following the plant-based plan lowered their daily insulin use by 28%, while those on a portion-controlled diet saw no meaningful change. Researchers say the reduced insulin requirement likely reflects improved insulin sensitivity. The original 2024 study reported additional benefits from the vegan diet. Participants lost an average of 11 pounds and showed improvements in insulin sensitivity and glycemic control. Cholesterol levels and kidney function also improved among those following the plant-based plan. https://www.sciencedaily.com/releases/2026/02/260212234212.htm XX Interesting little tidbit from the Winter Olympic Games.. the World Anti-Doping Agency (WADA) was monitoring GLP drug use. An advisory group that makes recommendations about WADA's list of prohibited substances discussed the status of GLP-1 medications, and added semaglutide (Ozempic, Wegovy, Rybelsus) and tirzepatide (Mounjaro, Zepbound) to its monitoring program That means patterns of use of these drugs will be tracked both in and out of competition.  The finding will be used to make recommendations about whether GLP-1 agonists should be added to the prohibited list, the spokesperson explained. While GLP-1 drug use is not currently prohibited, that could change before the next Summer Olympic Games in Los Angeles in 2028, he noted. https://www.medpagetoday.com/popmedicine/cultureclinic/119770 XX That's it for in the news!

Dr. Mark Tarnopolsky's VO2 max was once 87.6 ml/kg/min — an elite-level mark few humans have reached. He's competed at three world championships in three different sports. He's also had three cardiac ablation surgeries, bled from his bowels after races, and watched his vision tunnel to a speck crossing a finish line. His story is a master class in where the line falls between peak performance and self-destruction.Now 63, Tarnopolsky is a neurologist, neuromuscular disease specialist, and supplement formulator who has channeled decades of elite athletic experience and hundreds of published studies into the idea that keeping metabolic throughput high is what protects us as we age.In this conversation with Dom D'Agostino, he shares practical strategies anyone can apply: why resistance training three times per week is non-negotiable after 50, why post-exercise nutrient timing improved performance in a simulated training camp with identical calories, why he says creatine belongs in nearly everyone's regimen, and why he personally takes his mitochondrial supplement stack situationally after hard efforts rather than daily.Questions Answered in This Episode:What is the only intervention proven to extend human lifespan — and by how much?At what point does endurance exercise become pro-aging — and what are the warning signs?What simple nutrient timing strategy improved performance with zero extra calories?How did a bodybuilder bar conversation lead to a published discovery about growth hormone and collagen?What muscle and bone costs of Ozempic aren't getting enough attention?Why did elite endurance athletes need nearly as much dietary protein as bodybuilders — and why were bodybuilders massively overconsuming?This conversation reframes the longevity debate around what's actually been proven in human clinical trials — not Petri dishes, not animal models, and not social media influencers.Special thanks to the sponsors of this episode:✅ Troscriptions – Get 10% off your first order with code METABOLICLINK here.✅ Toups and Co – Get 15% off your first order with code METABOLIC here.✅ iRestore – Get a huge discount on the Elite and the Illumina bundle here. ✅ MudWtr – Get up to 43% off + free shipping and a free rechargeable frother with code METABOLICLINK here.In every episode of The Metabolic Link, we'll uncover the very latest research on metabolic health and therapy. If you like this episode, please share it, subscribe, follow, and leave us a comment or review on whichever platform you use to tune in!You can find us on all your major podcast players here and full episodes are also up on our Metabolic Health Summit YouTube channel!Find us on social: Instagram Facebook YouTube LinkedIn Please keep in mind: The Metabolic Link does not provide medical or health advice, but rather general information that does not serve as a substitute for a licensed healthcare professional. Never delay in seeking medical advice from an appropriately licensed medical provider for any health condition that you may have.

Send a textThis episode unpacks Novo's aggressive price cuts, Lilly's head to head trial win, and the emerging triple agonist race, revealing how pricing strategy and next generation data are colliding in a full scale GLP-1 market war.00:00 – Cold Open: Lilly vs Novo Shock TimingDave opens with the bombshell that Novo funded a tirzepatide trial while simultaneously announcing major price cuts to Wegovy and Ozempic, setting up a strategic chess match.03:20 – Novo Nordisk Price Cuts ExplainedDeep dive into Novo's plan to cut list prices by up to 50% and what that actually means for formulary power, PBMs, and competitive positioning.07:25 – Tirzepatide vs Semaglutide Head to Head TrialBreakdown of the direct comparison study showing stronger weight loss with tirzepatide and what that means clinically and commercially.11:55 – Market Reaction and Strategic ImplicationsDiscussion of stock movement, competitive signaling, and how Novo's pricing move may blunt Lilly's trial victory.14:25 – Novo Triple Agonist Data DropsShift into Novo's early phase data on its triple agonist candidate and how it compares conceptually to existing dual agonists.16:00 – Comparing Novo's Triple to RetatrutideAnalysis of weight loss percentages versus Lilly's retatrutide data and the caution required when comparing across trials.18:15 – The Triple Agonist EraBroader conversation about whether triple agonism consistently pushes weight loss higher and what durability may look like long term.20:00 – Clinical Trial Results vs Real World RealityReminder that clinical trial outcomes do not automatically translate to everyday patient experience.22:30 – Data Refresher on Allurion Ballon ApprovalQuick recap of the headline numbers and strategic landscape as innovation and pricing Visit TRYSHED.COM to learn more today! Use CODE OTP25 to save 25%!

Retirement planning isn't happening in isolation—it's intersecting with artificial intelligence, changing health trends, record market highs, and even rising grocery prices. In this episode of the Money Matters Podcast, Wes Moss and Connor Miller translate fast-moving headlines into balanced, long-term financial planning considerations designed to inform—not predict. • Assess how GLP-1 medications like Ozempic may be influencing workplace habits, health trends, and broader economic ripple effects. • Evaluate pronounced sector divergence in today's market, including defensive leadership in energy, materials, and consumer staples, alongside lagging technology and financials. • Examine how artificial intelligence may be reshaping industries and workforce expectations, particularly for professionals nearing retirement. • Analyze research suggesting AI adoption may shift competitive advantages toward workers who effectively integrate emerging tools. • Consider how the $27.40 savings framework may help structure retirement contributions while working toward milestones such as building a $10,000 reserve. • Explore automated savings strategies and income-based contribution benchmarks that may support consistency over time. • Review research indicating that written retirement plans may be associated with higher reported levels of happiness and financial confidence. • Recognize behavioral and psychological hurdles retirees often face when determining when—and how—to step away from work. • Break down the economic forces behind rising steak and ground beef prices, including cattle supply constraints and inflation dynamics. • Interpret market behavior at all-time highs by understanding how bull markets have historically unfolded through repeated peaks. Markets evolve, technology advances, and headlines shift—but disciplined, long-term thinking remains foundational. Listen and subscribe to the Money Matters Podcast for balanced financial education designed to provide perspective during an ever-changing economic landscape.

Welcome to Ozempic Weightloss Unlocked, where we dive into the latest on Ozempic from medical breakthroughs to real-life health impacts. Im here to unpack fresh news thats changing how we view this game-changer.A brand-new study from Rutgers University, published in the Journal of Medical Internet Research, reveals why so many stick with Ozempic despite side effects. Researchers analyzed sixty anonymous reviews on Drugs.com and found that sixty-two percent of users faced nausea, vomiting, or stomach issues, yet satisfaction soared when weight dropped. HealthDay News reports that sixty-seven percent experienced less appetite or fewer cravings for sugar and greasy foods, making the benefits outweigh the discomfort. Lead researcher Abanoub Armanious notes this cuts through social media hype to show everyday experiences: if youre losing weight, youre likely to keep going.Semaglutide, the key ingredient in Ozempic, mimics a hormone to control blood sugar, slow digestion, and curb hunger. Originally for type two diabetes, its now a weight loss powerhouse, with users seeing fifteen to twenty percent loss when paired with lifestyle tweaks, per UC Davis Health. But heres the catch: Physicians Committee research warns that stopping often leads to regaining two-thirds of the weight within a year, as the body rebounds with stronger cravings.Exciting advances are emerging. Georgia State Universitys Eric Krause found combining Ozempic-like drugs with anti-stress treatments boosts fat loss while sparing muscle and helps maintain results post-treatment. Plus, a daily oral semaglutide pill, approved this year, matches injections for thirteen to fifteen percent weight loss, according to Mount Sinai Health and the New England Journal of Medicine.Ozempic is transforming obesity care, but experts like those at UC Davis stress its best with diet, exercise, and doctor guidance to tackle root causes like stress or mental health hurdles. Note a recent retraction in the International Journal of Obesity on combo therapies, reminding us science evolves fast.Listeners, balance the wins with realities: results drive loyalty, but long-term success needs habits. Consult your doctor before starting.Thanks for tuning in, Ozempic Weightloss Unlocked listeners. Subscribe for more updates. This has been a quiet please production, for more check out quiet please dot ai. Some great Deals https://amzn.to/49SJ3QsFor more check out http://www.quietplease.aiThis content was created in partnership and with the help of Artificial Intelligence AI

GLP-1 drugs like Ozempic, Wegovy, and Mounjaro are everywhere, there in doctors’ offices, group chats, and comment sections. For some, they’re life-changing. For others, they raise uncomfortable questions about body image, privilege, and the pressure to be thin at any cost.But what doesn’t get talked about enough is what happens when you stop.In this episode, Brianne Cail opens up about her decision to start Ozempic and Mounjaro for health reasons and followed when she had to come off them. From the financial strain to the physical and emotional impact, we unpack the realities people don’t always share out loud.Because the truth about weight, money, and medical choice? It’s more complicated than a before-and-after photo. Ozempic, Monjaro, weight loss, body image, food noise, health, personal journey, societal standards, emotional impact, medication THE KIT ARTICLE

Are peptides the wellness world's newest miracle, or just the latest overhyped biohack? With ads for injectable weight-loss solutions everywhere you look and wellness influencers calling peptides the holy grail, we're taking a step back to unpack what's actually going on beneath the marketing. In this episode, we break down what peptides are, what they do in the body, and why they've suddenly exploded in popularity across both clinical and wellness spaces. We're also diving into the questions we know you're really asking—are peptide injections actually safe, who (if anyone) are they appropriate for, and what should give you pause? This conversation walks through the mechanisms, risks, and real-world considerations from a functional medicine lens as well as how you can get similar results without subjecting yourself to expensive weekly injections.   Also in this episode:  Relax and Regulate now reformulated - use RELAX15 for 15% off What are peptides? Episode 474 Hack Your Health Recap: A-ha's and New Products Ali is Stoked About Sourcing and mechanism of action Applications of peptides Naturally sequenced peptides vs. unnatural amino acids Cellular Antiox Pure Collagen Concerns of peptides Episode 323 Ozempic, Wonder Drug or Too Good to be True? Episode 359 Oh-No Ozempic Updates, Berberine and Keto How to naturally increase GLP-1 Berberine Boost Super Turmeric Adaptogen Boost EPA DHA Extra Restore Baseline Probiotic How to mimic tissue repair from BPC-157  Pure Collagen Bio-C Plus EPA DHA Extra GI Lining Support Super Turmeric Episode 293 How to Get More Fish in the Diet Tuna Salad with 2 Secret Ingredients What you can use for beauty besides GHK-Cu Lifewave Patches Micronutrient Panel Risks of peptides Why keto will make a comeback Archive Keto Program Advanced Metabolic Panel This episode is sponsored by Naturally Nourished Relax and Regulate Relax & Regulate has always been a superstar for sleep, stress, and hormone support, and we've taken a good thing and made it even better! We've seen incredible results with 1000's of clients using Relax and Regulate literally every day for 10+ years now.    We have increased magnesium bisglycinate from 200 mg to 250 mg to match clinical sleep research dosing, kept myo-inositol at the full 4-gram therapeutic dose, and improved the supporting ingredients so the entire formula is better absorbed, better tolerated, and more aligned with what we're seeing clinically every day. Use code RELAX15 to save 15% on our reformulated Relax and Regulate!   

This is a free preview of a paid episode. To hear more, visit abbieattwoodwellness.substack.comFiber is having a moment — and like most wellness trends, the story is more layered than the headlines suggest. In this episode, we're slowing down the “fibermaxxing” conversation and coming at it through the lens of science, context, and a compassionate relationship with food.In this episode, we discuss:* What the fibermaxxing trend is, what the research actually says about fiber's benefits, and where those benefits level off* How diet culture turns neutral nutrition advice (remember protein?) into extremes and appetite-control strategies* The difference between supporting fullness and suppressing hunger — especially in today's GLP-1 and “nature's Ozempic” era* Why this messaging can be particularly tricky for those healing from disordered eating or volume-eating patterns* How to approach fiber in a way that supports health without sacrificing nourishment, satisfaction, or trust in your bodySupport the show: Enjoying this podcast? Please support the show on Substack for bonus episodes, community engagement, and access to "Ask Abbie" at abbieattwoodwellness.substack.com/subscribe Apply for Abbie's Group Membership:Already been at this anti-diet culture thing for a while, but want community and continued learning? Apply for Abbie's monthly membership: https://www.abbieattwoodwellness.com/circle-monthly-group Social media:Find the show on Instagram: @fullplate.podcastFind Abbie on Instagram: @abbieattwoodwellness Podcast Cover Photography by Anya McInroyPodcast Editing by Brian WaltersThis podcast is ad-free and support comes from your support on Substack. Subscribe HERE.

É fato, a patente do Ozempic cai pro chão agora em março e abre as portas para versões nacionais e genéricas do medicamento e também de uma corrida bilionária para as farmacêuticas e a promessa é muito simples:    Tome o remedinho e veja sua gordura ir embora sem que você precise fazer mais nada.    Uma verdadeira maravilha, um milagre da ciência prestes a estar acessível a todo mundo. Finalmente nós vamos ter uma solução fácil e barata para o sobrepeso que já atinge 68% dos brasileiros.    Por isso, não tem mais porque eu fazer vídeos aqui, então, foi bom enquanto durou, eu vou fechar o canal e um grande abraço, tchau!    Hmmm.... mas calma lá, calma lá... tem muito mais minhoca neste buraco do que a maioria sequer tem idéia... vem comigo  

Discover how to lose weight without Ozempic using 5 evidence-backed strategies. This episode breaks down why insulin resistance is the real driver of weight gain and how cutting processed foods, eating only when hungry, fasting, weight resistance training, and detoxification can help you lose weight naturally and sustain it long-term — no prescription required. FEATURED PRODUCT The Good Poops Protocol is designed to support the exact systems discussed in this episode — liver detoxification, gut health, and blood sugar regulation. 

TO LEARN MORE:       www.CrossFitEdwardsville.com       www.Facebook.com/CrossFitEdwardsville      TikTok: @crossfitedwardsville      Instagram: @crossfitedwardsville        Twitter: @cfedwardsville        YouTube: CrossFit Edwardsville TO GET STARTED AT CFE:     Book a No-Sweat Conversation with a coach, using this scheduler:          https://crossfitedwardsville.com/intro/    You can also find the link to schedule on our website. While this show is educational & entertaining in nature, it does not replace or supplant professional medical guidance from your own physician. Before beginning any exercise or nutrition program, please first consult with your doctor. 

It's our 100th episode, y'all. And if you've been with us since episode one… or you just found your way here… welcome home.   This episode is laughter, reflection, growth, healing, honesty, and a whole lot of sister energy. We brought back our original co-host Maria Shelton to celebrate where we started and how far we've come.   From sneaking out stories and getting arrested (yes, we went there) to healing after divorce, falling in love again, body image conversations, Ozempic honesty, business dreams, and control issues… nothing was off limits.   When we started this podcast, we were in the middle of separation, divorce, heartbreak, and rebuilding. And now?   One is engaged and in her soft girl era. One is thriving in co-parenting growth. One is choosing herself and her health in new ways.   This is what Got HER Back has always been about. Real women. Real stories. Real growth.   You've got her back. And we've got yours. Always.   Chapters: 00:00 Did Your Siblings Snitch On You? 01:00 It's Our 100th Episode! 02:00 Football Recruiting & Mom Life 04:00 Date Night at Delilah's 05:00 Social Media & Content Creator Life 08:00 From Divorce to Healing 10:00 Pilates Era & Soft Girl Energy 11:30 Ozempic Honesty & Body Talk 16:00 Favorite Episodes Over 100 Shows 18:00 Conversation Card Game Begins 19:00 Fortune Teller Question 20:00 Sneaking Out Stories 22:00 Worst Dates Ever 24:30 Dream Visitations From Loved Ones 27:00 Businesses We'd Start Today 29:30 Have You Ever Been Arrested? 32:00 Favorite Feature of Our Partners 34:00 Which Sense Would You Keep? 35:00 Lottery or 10 More Years of Life? 36:00 What We've Been Avoiding 38:00 Control Issues & Clean Kitchens 40:00 Will Maria Come Back?  

Are you worried GLP-1 medications will make coaches obsolete? Medications like Ozempic, Wegovy, and Mounjaro are changing the weight loss conversation, but they're not replacing the work coaches do. In fact, they're making behavior change coaching more essential than ever.In this episode, Dr. Kasey Jo Orvidas breaks down what GLP-1s actually do, why 50-75% of users stop taking them within a year, and how coaches can support clients using these medications while staying ethically grounded and professionally valuable.You'll learn:What GLP-1 medications actually do (and what they don't teach clients about behavior change, mindset, or long-term habits)Why people still need coaches even when medication accelerates weight lossHow to navigate the ethical dilemma of posting client transformations when GLP-1 use is involvedSix ways coaches can support clients on GLP-1s, from muscle preservation to managing identity shifts and shameWhy the future of coaching requires more psychology, communication skills, and mindset work (not less)Watch the full episode on YouTube: https://youtu.be/gKmAYVkVbDgRegister for my FREE 3-Day Training: The Coaching CodeConnect with me on Instagram! Grab 5 Free Lessons in Mindset and Behavior Change Coaching [HMCC WAITLIST]LEAVE A REVIEW, WIN A WORKSHOP! After you leave your review, take a screenshot and upload it to this form to be entered to winWant me to answer your questions on my next Q&A episode? Drop your questions here!Related Topics: GLP-1 medications for weight loss, Ozempic and coaching, Wegovy and fitness coaches, coaching clients on weight loss medication, behavior change coaching, mindset coaching with GLP-1s, ethical coaching practices, client transformation ethics, future of health coaching, weight loss medication support, coaching industry trends, muscle preservation on GLP-1s, sustainable weight loss habits

In this episode, Gianna Beasley interviews Aja Beckett, the founder of Shotsy, a companion app for individuals on GLP-1 medications. Aja shares her personal journey with obesity and the challenges she faced before discovering GLP-1s. We dive into the struggles of weight management, the creation of the Shotsy app, its features, and the importance of community support. Shotsy is a mobile health tracking app specifically designed for people using GLP-1 medications like Ozempic, Wegovy, Mounjaro, Zepbound, Semaglutide, and Tirzepatide. It helps users monitor their injection schedule, side effects, and progress toward goals like weight loss or health improvements. Aja discusses the app's freemium model, ensuring accessibility for all users, and discusses the significance of building trust within the GLP-1 community.Download Shotsy in the App Store on Apple or Android!

Dr. Daniel Drucker's research helped pave the way for Ozempic, the blockbuster GLP-1 class drug. The endocrinologist has been researching the effects on Ozempic's active ingredient semaglutide in the body for decades.Today he'll show us around his lab and explain how a stout lizard kept in a freezer helped unlock the science behind a drug taken by more than a million Canadians.  Then, health reporter Kelly Grant tells us about rising obesity rates in Canada, and we'll hear from a doctor who prescribes GLP-1s— and a patient who takes them.  This is part of a three-part series. The next episode is next Monday, March 2nd.  You can contact the National Eating Disorders Information Centre at their toll-free hotline at 1-866-NEDIC-20 or visit their website. Questions? Comments? Ideas? Email us at thedecibel@globeandmail.com Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

We sit down with Chris Sulak aka CJ the DJ and dry camper Ron Alvarez to talk about a new initiative petition in Oregon, the 1847 Colt Walker, mailing a handgun to yourself, Ozempic, Bill Gates Butter and Sprinter Vans. And as a public service CJ the DJ delivers three Craigslist missed connections from Springfield and Salem, Oregon. And before you listen, we apologize.If you want to support free speech and good hunting content on the Information Superhighway, look for our coffee and books and wildlife forage blends at https://www.garylewisoutdoors.com/Shop/This episode is sponsored by West Coast Floats, of Philomath, Oregon, made in the USA since 1982 for steelhead and salmon fishermen. Visit https://westcoastfloats.com/Our TV sponsors include: Nosler, Camp Chef, Warne Scope Mounts, Carson, ProCure Bait Scents, The Dalles Area Chamber of Commerce, Madras Ford, Bailey Seed and Smartz.Watch select episodes of Frontier Unlimited on our network of affiliates around the U.S. or click https://www.youtube.com/results?search_query=gary+lewis+outdoors+frontier+unlimited

» Produced by Hack You Media: pioneering a new category of content at the intersection of health performance, entrepreneurship & cognitive optimisation.Instagram: https://www.instagram.com/hackyoumedia/Website: https://hackyou.media/Trusted source for peptides: bioniqlab.comDN Lab Research: Dnlabresearch.comDean Henry has spent 11 years deep in peptide research after his misdiagnosed ACL led him down the regenerative medicine rabbit hole, and this conversation reveals why therapeutic peptides work completely differently than peptide drugs, and how to avoid toxic contamination from sketchy labs.Learn why the raw material might be fine, but contamination happens during filling in unsterile environments, how micro-dosing triple agonists for longevity differs drastically from medical protocols, and why combining growth hormone peptides with recovery compounds optimises results.00:00 Introduction02:10 Peptides 101 and their sudden mainstream popularity08:45 Dangers of “peptide drugs” like Ozempic and receptor burnout12:33 Red flags when buying or being sold peptides online17:10 Why the peptide's container matters more than people think18:20 Retatrutide and the future of weight loss peptides21:04 Cycling peptides safely and avoiding harsh rebounds28:25 BPC-157 for connective tissue recovery and pain reduction34:17 Growth hormone peptides that optimise without suppression37:06 Safe starter blends for building muscle and recovering faster40:43 Peptides that can boost testosterone naturally, not replace it44:04 Cognitive enhancers like Semax, Selank and Dihexa49:42 Sleep-enhancing peptides and managing dependency risks52:58 GHK-Cu for skin, hair growth, and collagen regeneration56:50 The gut health stack: BPC, KPV, Lorazotide and more01:01:40 Peptides can support healing, but not replace lifestyle01:05:15 Sketchy protocols, histamine responses and what to avoid01:10:04 How to safely explore peptides with professional guidance» Escape the 9-5 & build your dream life - https://www.digitalplaybook.net/» Transform your physique - https://www.thrstapp.com/» My clothing brand, THRST - https://thrstofficial.com» Custom Bioniq supplements: https://www.bioniq.com/mikethurston• 40% off your first month of Bioniq GO• 20% off your first month of Bioniq PRO» Join our newsletter for actionable insights from every episode: https://thrst-letter.beehiiv.com/» Join WHOOP and get your first month for free - join.whoop.com/FirstThingsThrst» Follow DeanInstagram: https://www.instagram.com/dean.e.henry/?hl=enWebsite: https://uaepeptides.com/author/deanuaepeptides-com/

Ozempic may help you lose weight—but only temporarily. Drs. Klaper and Fuhrman explain why lifestyle medicine is the true long-term solution. #OzempicMyths #LifestyleMedicine #WeightLossTruth

McDonald's and other fast food restaurants are losing business because of GLP-1s including Ozempic. Now they're pivoting to protein to try and keep customers. So secret McDonald's Ozempic menu when?Watch the podcast episodes on YouTube and all major podcast hosts including Spotify.CLOWNFISH TV is an independent, opinionated news and commentary podcast that covers Entertainment and Tech from a consumer's point of view. We talk about Gaming, Comics, Anime, TV, Movies, Animation and more. Hosted by Kneon and Geeky Sparkles.Get more news, views and reviews on Clownfish TV News - https://more.clownfishtv.com/On YouTube - https://www.youtube.com/c/ClownfishTVOn Spotify - https://open.spotify.com/show/4Tu83D1NcCmh7K1zHIedvgOn Apple Podcasts - https://podcasts.apple.com/us/podcast/clownfish-tv-audio-edition/id1726838629

El divulgador científico Manuel Toharia analiza una cuestión que está despertando un notable interés: la posibilidad de que los nuevos medicamentos contra la obesidad, como la semaglutida, conocida comercialmente como Ozempic, puedan también influir en otras adicciones. Aunque los medios llevan meses mencionándolo, los datos aún son preliminares y la comunidad científica pide cautela. Aun así, la hipótesis abre un campo de investigación prometedor sobre cómo estos fármacos podrían modular ciertos comportamientos compulsivos.Toharia comenta además dos descubrimientos recientes que amplían nuestra comprensión del mundo: por un lado, un bonobo que ha demostrado ser capaz de imaginar una acción sin realizarla, lo que sugiere que la imaginación no es un rasgo exclusivamente humano. Por otro, la confirmación, gracias al telescopio espacial más potente disponible, de una galaxia formada muy poco después del Big Bang, un hallazgo que nos acerca un poco más a los orígenes del universo.Escuchar audio

Are you exhausted, hoping for the next miracle plan to finally work? In this episode, Heather Creekmore gets real about the emotional toll of constantly chasing weight loss, sharing personal stories about everything from Special K diets to cottage cheese pizza and the roller coaster of hope and disappointment. Heather Creekmore discusses: The overwhelming pressure brought on by social media and the constant marketing of new supplements and gadgets How the pursuit of “fixing” your body can feel like a never-ending DIY project The impact of aging on body image expectations and responsibilities, especially for women The spiritual aspect of exhaustion, questioning whether the battle has taken too much from us and reminding listeners that our identity and value are found in Christ—not in achieving a specific body goal Biblical insight on rest, referencing Jesus’ words in Matthew 11:28-30, and the invitation to find a refreshing, restorative break instead of a relentless treadmill How pursuing goals from a place of rest (rather than stress and striving) could transform your weight loss journey Ready to exhale and approach your goals from a new angle?Join the ongoing conversation in the free Waiting for Weight Loss community: waitingforweightloss.com. Episodes drop Mondays, Wednesdays, and Fridays during Lent. Resources & Links Waiting for Weight Loss Community (waitingforweightloss.com) This is a private app available for community engagement Takeaway:You don’t have to white-knuckle your way through weight loss. Jesus offers real rest—no more holding your breath. Subscribe, join the community, and continue this journey toward peace-filled progress. Connect: Podcast: Compared to Who? Community: Waiting for Weight Loss (waitingforweightloss.com) Next Episode:We’ll dig deeper into practical ways you can exhale and rest in your journey—don’t miss it! Discover more Christian podcasts at lifeaudio.com and inquire about advertising opportunities at lifeaudio.com/contact-us.

What if weight loss isn't about discipline—but about biology? In this episode of Healthy Looks Great on You, Dr. Vickie welcomes Dr. Suzanna Chatterjee-Morris, a board-certified OB-GYN and obesity medicine physician, for a fascinating conversation about GLP-1 medications and what they really do inside the body. Together, they take listeners to mini medical school to break down: What GLP-1 medications are and how they affect insulin resistance and metabolism Why weight gain is often a medical issue—not a personal failure How GLP-1s are being used beyond weight loss, including PCOS, infertility, fatty liver disease, sleep apnea, and cardiovascular health What the research shows about long-term benefits and reduced all-cause mortality Common concerns like muscle loss, weight regain, and “Ozempic face” Why nutrition, protein intake, and exercise are essential when using these medications Dr. Chatterjee also explains the concept of weight “set point,” why stopping these medications too soon often leads to regain, and how GLP-1s work best when paired with sustainable lifestyle changes—not willpower alone. If you've been curious or confused about Ozempic, Wegovy, Zepbound, or similar medications, this episode offers clarity, evidence, and reassurance—without hype or shame.

Queda de cabelo, fraqueza e intestino parado. Vamos falar do preço metabólico da falta de nutrientes e como reverter isso.Bônus: Suplementos que podem ajudar para quem estiver usando GLP-1Se você está usando análogos de GLP-1 (como Ozempic, Mounjaro, Wegovy) para emagrecer, é provável que esteja feliz com os números caindo na balança, mas... exausta na vida real.Sabe aquela sensação de corpo pesado? De fraqueza para subir um lance de escada? Aquele cabelo caindo mais que o normal e uma “névoa” mental que não passa?Não, não é “coisa da sua cabeça”. E não vale colocar na conta da menopausa também não. E não, não é o preço que você precisa necessariamente pagar para ser magra — se souber fazer direito.Compreenda por que emagrecer sem suporte metabólico leva à magreza frágil, ao efeito rebote e ao colapso da vitalidade. E, principalmente, como usar essas medicações do jeito certo, com estratégia, nutrição e proteção muscular.Neste episódio, você vai aprender:Por que estar magra não significa estar saudávelComo a perda de apetite leva ao modo racionamento metabólicoO risco real da perda muscular silenciosa com GLP-1Por que perder músculo acelera o envelhecimento e o efeito reboteO impacto das “canetinhas” no intestino, digestão e SIBOComo fazer o uso correto dos GLP-1 com suporte metabólicoEstratégias de proteína, treino e suplementação para preservar energiaComo reverter cansaço, fraqueza, queda de cabelo e intestino paradoMeu livro Perimeno Quê? O manual que eu queria ter tido quando eu passei pela perimenopausa já está disponível para vendas.

What if the secret to healing your body isn't a prescription, it's on your plate?In this episode, Dr. William Li reveals the groundbreaking science behind how everyday foods can activate your body's natural defense systems, lower inflammation, and even reverse chronic disease. Dr. Li is an internationally renowned physician, scientist, and New York Times bestselling author of Eat to Beat Disease and Eat to Beat Your Diet. His research has led to the development of more than 40 new medical treatments impacting care for over 70 diseases.If you've ever felt confused about what to eat or frustrated that doctors don't talk about nutrition, this conversation will change everything. You'll discover why health isn't just the absence of disease, the shocking truth about inflammation and how to put it out fast, Dr. Li's simple gut health strategy that works overnight, how to detox your liver naturally, and why the "clean plate club" myth has been sabotaging your metabolism since childhood.Dr. Li also shares metabolism-boosting beverages, the natural "Viagra effect" hiding in beets and spinach, what GLP-1 drugs like Ozempic are really doing to your body, and a 60-second breathing technique that generates nitric oxide in your brain for instant mental clarity.This is food as medicine at its finest, practical, science-backed, and actually delicious.Ready to take control of your health? Hit follow and never miss an episode.

Millions of Americans are turning to GLP-1 weight loss medications like Ozempic and Wegovy. But here's the question few are asking: What happens when you stop? Research shows that many people regain a significant portion of the weight within a year of discontinuing GLP-1 medications. In some studies, participants regained as much as two-thirds of the weight they lost. On this episode of The Exam Room, Chuck Carroll sits down with world-renowned obesity researcher James Hill, PhD to unpack the real story behind long-term weight management after GLP-1 medications. Dr. Hill is a pioneering scientist and former president of The Obesity Society and The American Society for Nutrition. Along with Dr. Holly Wyatt, he co-authored the new book Losing the Weight Loss Meds: A 10-Week Playbook for Stopping GLP-1 Medications Without Regaining the Weight. In this conversation, you'll learn: • Are GLP-1 medications meant to be long-term? • What happens inside the body when you stop taking them • Why so many people regain weight after discontinuing • The 10-week transition strategy for maintaining weight loss • The three types of weight regain—and how to avoid each • How to quiet food noise and cravings naturally • Daily habits that can replace the work of GLP-1 medications Chuck also shares his personal perspective on long-term weight loss success, including: • What he's learned after weight loss surgery • The lifestyle shifts that made his results sustainable • And what he wishes he knew before surgery that he knows now If you're considering GLP-1 medications, currently using them, or thinking about stopping, this episode could change how you approach weight maintenance forever.

Ozempic is everywhere, and the conversation around it reveals far more than a debate about weight loss. Ray, E.Z., Mark, and Oscar step into the cultural moment surrounding GLP-1 medications, clarifying their medical purpose while asking more profound questions about motive, discipline, and identity. The guys acknowledge that these drugs have saved lives, especially for those with type two diabetes, but they focus on the growing trend of using them as shortcuts to self-control and image management. What emerges is a challenge to examine why so many are willing to chemically alter their bodies in pursuit of a certain look, and what that pursuit reveals about the desires shaping the heart.The discussion widens to the obsession with perfection and comfort that shapes modern life. The guys describe how we live in a filtered and photoshopped world where appearance becomes currency and praise becomes addictive. Ozempic, they argue, functions as a cultural artifact that exposes a lack of discipline and an unwillingness to embrace discomfort. This shortcut mindset shows up not only in health but also in faith, work, and ministry, where people want outcomes without formation. Discipline, once seen as virtuous, is now treated as oppressive, yet Scripture calls believers to discipline themselves for godliness rather than convenience.Contentment becomes a central theme as the guys contrast cultural messaging with a biblical worldview. Advertisers thrive by sowing dissatisfaction, but Scripture calls believers to gratitude, stewardship, and eternal perspective. Identity is often tied to the scale or the mirror, yet value is rooted in belonging to Christ. Oscar shares practical wisdom about food as fuel rather than a fixation, modeling balance rather than restriction or obsession. Ray emphasizes enjoying God's gifts without letting them rule us, reminding listeners that health is complex and cannot be reduced to appearance alone.The conversation closes with a call to examine judgment, pride, and purpose. The body is not a trophy to display but a temple to steward, and viewing it rightly frees believers from comparison and condemnation. Psalm 139 affirms God's intentional design, pushing back against cultural pressure to reshape what God has formed. True contentment comes from denying self, following Christ, and living for eternal glory rather than temporary praise. There are no shortcuts to sanctification, only grace, discipline, and a life oriented toward making Christ known rather than making ourselves admired. Send a textThanks for listening! If you've been helped by this podcast, we'd be grateful if you'd consider subscribing, sharing, and leaving us a comment and 5-star rating! Visit the Living Waters website to learn more and to access helpful resources!You can find helpful counseling resources at biblicalcounseling.com.Check out The Evidence Study Bible and the Basic Training Course.You can connect with us at podcast@livingwaters.com. We're thankful for your input!Learn more about the hosts of this podcast.Ray ComfortEmeal (“E.Z.”) ZwayneMark SpenceOscar Navarro

U.K. authorities on Thursday arrested Andrew Mountbatten-Windsor on suspicion of "misconduct in public office." Police had previously said they were investigating whether the former prince sent confidential trade documents to the late sex offender Jeffrey Epstein. Liz Stein, a survivor of Epstein's abuse and an anti-trafficking advocate, joins us.Then, Meta's Mark Zuckerberg appeared in a Los Angeles court on Wednesday to defend his company against a lawsuit that alleges social media harms children. LA Times reporter Sonja Sharp breaks down the trial so far.And, GLP-1 medications could help treat alcohol and drug addiction, experts say. Addiction specialist Dr. Mark S. Gold explains how medications such as Ozempic and Wegovy are prompting "a reconceptualization of addiction itself."Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

I've been sick all week, and it completely disrupted my plans, my workouts, and the momentum I thought I was building.In this episode, I'm talking about what it feels like when your body forces you to rest — and why we often only “allow” ourselves to slow down when we're physically unwell. If you're feeling behind, off track, or like you have to start over, this is your reminder: you're not starting over. You're continuing.Show Notes!

GLP-1s and bariatric surgery are powerful medical tools, and the real risk is starting them without understanding what long-term weight maintenance actually requires.This conversation pulls obesity treatment out of the culture wars and back into medicine. Dr. Betsy Dovec, one of the most experienced bariatric surgeons in the country,speaks plainly about what long-term care actually demands, whether someone chooses bariatric surgery, GLP-1 medications, or a combination of both. The question beneath it all is simple and uncomfortable: are you looking for a short-term result, or are you prepared for a long-term strategy?There is honesty here about weight regain, about the reality that stopping GLP-1 medications often leads to reversal, and about why a plan for maintenance matters more than the initial drop on the scale. The discussion touches on Microdosing GLP-1, the rise of GLP-1 oral medication, and how access and expectations shape outcomes. It also moves into GLP-1 for menopause and perimenopause, acknowledging how hormones change the metabolic equation for women and why GLP-1 inflammation benefits may explain why some feel better beyond weight loss alone.This episode challenges the shame narrative. Obesity is treated as a chronic metabolic condition influenced by biology, environment, and hormones. The deeper takeaway is not which tool to choose, but whether you are approaching your health with clarity about what sustainable care truly involves.Episode Breakdown:00:00 Bariatric Surgery Explained: What It Really Is09:11 Long-Term Weight Loss Success and Maintenance Strategies11:57 GLP-1 Medications, Ozempic, and Weight Regain Reality18:04 Hormones, Perimenopause, and GLP-1 for Women28:00 Visceral Fat, Fatty Liver, and Metabolic Risk37:01 Modern Bariatric Surgery and Recovery TimelineConnect with Dr. Betsy Dovec:Follow Dr. Dovec's InstagramVisit BodyByBariatrics WebsiteFollow BodyByBariatrics TikTok⁠⁠⁠⁠For More on this Episode: Read the full show notes ⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠

Jared Freid welcomes comedian Shaun Murphy to Chit Chat Wednesday for a wide-ranging hang that covers stand-up life, dating, body image, nerd culture, and what happens when your comedy special includes a joke about your own skinny dick. Shaun talks about his new YouTube special Long Story Thin, growing up in Buffalo, balancing sports fandom with nerd energy, and navigating family, relationships, and confidence on stage. The two dig into watching other comedians, staying relatable when success hits, Ozempic, cookie rankings (Tate's truthers unite), Star Wars vs Harry Potter, and why Andor might actually be the best show ever made. Plus, Jared puts Shaun through a “Nerd or Not a Nerd” game that somehow connects Zelda, Buffalo Bills trauma, and comedy authenticity.Check out Shaun's new special today!

Zohran Mamdani's plan to fix New York City's budget crisis involves pressuring Albany to soak the rich with higher income taxes on millionaires and bigger levies on profitable corporations, claiming it's the "fairest" way to avoid hurting working families. If state leaders refuse, he threatens a massive 9.5% city property tax hike as a backup, which would slam homeowners, co-op residents, and middle-class New Yorkers. This ultimatum-style approach is designed to force higher taxes on the wealthy by holding property owners hostage. How is the warmth of collectivism now in New York?  We Also Cover: Customer service call centers. Savannah Guthrie writes about a kidnapping. Taking your calls. Ozempic houses are a thing?  Poop on the sidewalks of New York City. Property taxes are immoral. Whoopi Goldberg is in the Epstein files. 00:00 Pat Gray UNLEASHED! 00:33 Complaining about Call Centers 11:25 Caller Scott 14:24 Bizarre Excerpt from Savannah Guthrie's Book 24:59 More Information on Rhode Island Shooting 36:27 Chewing the Fat 54:29 Caller Rob 1:04:54 Ozempic Houses 1:13:52 Zohran Mamdani Releases New NYC Budget 1:18:41 Zohran Mamdani's Property Tax Hike 1:21:56 Zohran Mamdani Explains Why He's Raiding the Reserves 1:30:59 Whoopi Goldberg is on the Epstein List 1:33:32 Who Exactly is on the Epstein List? Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, Mike talks discusses the most common mistake that most people make when it comes to dieting and fat loss. Both from a mindset perspective and from a tactical perspective. He also shares a simple shift that will help you see sustainable results.------------------------------------------------Click here to apply for coaching!For some amazing resources and to be a part of a badass community, join our FB group HEREThe personality assessment is now available online! Click here to take the assessment and find out what your personality tells us about the way you should be training and eating.Take the assessment here!To learn more about Neurotyping, visit www.neurotypetraining.comFollow Mike on IG at @coach_mike_millner

Ozempic has become a cultural flashpoint that exposes deeper issues of discipline, identity, and the pursuit of approval. Ray, E.Z., Mark, and Oscar explore how GLP-1 medications, while medically helpful for some, are increasingly used as shortcuts to self-control in a culture obsessed with comfort, image, and instant results. The guys wrestle with the motives behind using these drugs, asking whether the desire is rooted in health or in the need for affirmation and praise, and they connect this trend to a broader pattern of wanting outcomes without formation. They emphasize that the body is a temple meant to serve the Lord rather than a trophy to impress others, calling believers to pursue contentment, practice godly discipline, and find lasting identity in Christ rather than in appearance or quick fixes. The conversation ultimately points listeners toward eternal mindedness, reminding them that true freedom and transformation come not from altering the body, but from being shaped by Christ.Send a textThanks for listening! If you've been helped by this podcast, we'd be grateful if you'd consider subscribing, sharing, and leaving us a comment and 5-star rating! Visit the Living Waters website to learn more and to access helpful resources!You can find helpful counseling resources at biblicalcounseling.com.Check out The Evidence Study Bible and the Basic Training Course.You can connect with us at podcast@livingwaters.com. We're thankful for your input!Learn more about the hosts of this podcast.Ray ComfortEmeal (“E.Z.”) ZwayneMark SpenceOscar Navarro

There is a national push for rapid weight loss with drugs like Ozempic. These drugs carry a high risk of adverse health issues and create a dependency that injects artificial agents into the body to mimic what that body does naturally. Our nation is in a health crisis. Big Pharma's solution is to override your body systems with their poisons. A whole body health approach helps the body reset  its systems and naturally restore and rejuvenate the body temple. It also allows the genes of the body to express their full potential... known as epigenitics. The goal is to give the body what it needs to over come sickness and restore itself to its fullest potential.  #BardsFM_HealthAndWellness #WeightLoss #Epigenetics Bards Nation Health Store: www.bardsnationhealth.com EnviroKlenz Air Purification, promo code BARDS to save 10%: www.enviroklenz.com EMPShield protect your vehicles and home. Promo code BARDS: Click here MYPillow promo code: BARDS >> Go to https://www.mypillow.com/bards and use the promo code BARDS or... Call 1-800-975-2939.  White Oak Pastures Grassfed Meats, Get $20 off any order $150 or more. Promo Code BARDS: www.whiteoakpastures.com/BARDS BardsFM CAP, Celebrating 50 Million Downloads: https://ambitiousfaith.net Morning Intro Music Provided by Brian Kahanek: www.briankahanek.com Windblown Media 20% Discount with promo code BARDS: windblownmedia.com Founders Bible 20% discount code: BARDS >>> TheFoundersBible.com Mission Darkness Faraday Bags and RF Shielding. Promo code BARDS: Click here EMF Solutions to keep your home safe: https://www.emfsol.com/?aff=bards Treadlite Broadforks...best garden tool EVER. Promo code BARDS: TreadliteBroadforks.com No Knot Today Natural Skin Products: NoKnotToday.com Health, Nutrition and Detox Consulting: HealthIsLocal.com Destination Real Food Book on Amazon: click here Images In Bloom Soaps and Things: ImagesInBloom.com Angeline Design: AngelineDesign.com DONATE: Click here Mailing Address: Xpedition Cafe, LLC Attn. Scott Kesterson 591 E Central Ave, #740 Sutherlin, OR  97479  

Dhruv Khullar, practicing physician, associate professor of health policy and economics at Weill Cornell Medical College and contributing writer at The New Yorker, talks about the effect GLP-1 drugs, like Ozempic, are having on curbing addictions and what researchers are studying about that phenomenon.Photo by: Michael Siluk/UCG/Universal Images Group via Getty Images